메뉴 건너뛰기




Volumn 29, Issue 3, 2007, Pages 285-288

High activity of meropenem against Gram-negative bacteria from a paediatric Intensive Care Unit, 2001-2005

Author keywords

Gram negative bacteria; Intensive Care Unit; Meropenem; MIC; Susceptibility

Indexed keywords

BETA LACTAMASE AMPC; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

EID: 33846916498     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.09.012     Document Type: Article
Times cited : (9)

References (16)
  • 2
    • 0035873724 scopus 로고    scopus 로고
    • Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region
    • Winokur P.L., Canton R.R., Casellas J.M., and Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 32 Suppl. 2 (2001) S94-S103
    • (2001) Clin Infect Dis , vol.32 , Issue.SUPPL. 2
    • Winokur, P.L.1    Canton, R.R.2    Casellas, J.M.3    Legakis, N.4
  • 3
    • 0036234603 scopus 로고    scopus 로고
    • Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000
    • Pfaller M.A., and Jones R.N. Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000. Int J Antimicrob Agents 19 (2002) 383-388
    • (2002) Int J Antimicrob Agents , vol.19 , pp. 383-388
    • Pfaller, M.A.1    Jones, R.N.2
  • 4
    • 0033825147 scopus 로고    scopus 로고
    • MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview
    • Turner P.J. MYSTIC (Meropenem Yearly Susceptibility Test Information Collection): a global overview. J Antimicrob Chemother 46 Suppl. T2 (2000) 9-23
    • (2000) J Antimicrob Chemother , vol.46 , Issue.SUPPL. T2 , pp. 9-23
    • Turner, P.J.1
  • 5
    • 33846909191 scopus 로고    scopus 로고
    • National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial test for bacteria that grow aerobically. Document M7-A6. Wayne, PA: NCCLS; 2003.
  • 6
    • 33846920785 scopus 로고    scopus 로고
    • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Document M100-S13. Wayne, PA: NCCLS; 2003.
  • 7
    • 33646917499 scopus 로고    scopus 로고
    • The use of fluoroquinolones in children
    • Leibovitz E. The use of fluoroquinolones in children. Curr Opin Pediatr 18 (2006) 64-70
    • (2006) Curr Opin Pediatr , vol.18 , pp. 64-70
    • Leibovitz, E.1
  • 8
    • 0041360586 scopus 로고    scopus 로고
    • Fluoroquinolones in paediatrics: a risk for the patient or for the community?
    • Gendrel D., Chalumeau M., Moulin F., and Raymond J. Fluoroquinolones in paediatrics: a risk for the patient or for the community?. Lancet Infect Dis 3 (2003) 537-546
    • (2003) Lancet Infect Dis , vol.3 , pp. 537-546
    • Gendrel, D.1    Chalumeau, M.2    Moulin, F.3    Raymond, J.4
  • 9
    • 0036236867 scopus 로고    scopus 로고
    • Susceptibility patterns of Gram-negative bacteria from a Polish intensive care unit, 1997-2000
    • Patzer J., Dzierżanowska D., and Turner P. Susceptibility patterns of Gram-negative bacteria from a Polish intensive care unit, 1997-2000. Int J Antimicrob Agents 19 (2002) 431-434
    • (2002) Int J Antimicrob Agents , vol.19 , pp. 431-434
    • Patzer, J.1    Dzierzanowska, D.2    Turner, P.3
  • 10
    • 0035682004 scopus 로고    scopus 로고
    • MYSTIC Program: summary of European data from 1997 to 2000
    • Goossens H. MYSTIC Program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis 41 (2001) 183-189
    • (2001) Diagn Microbiol Infect Dis , vol.41 , pp. 183-189
    • Goossens, H.1
  • 11
    • 29944445902 scopus 로고    scopus 로고
    • Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997-2002)
    • Masterton R.G., and Turner P.J. Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997-2002). Int J Antimicrob Agents 27 (2006) 69-72
    • (2006) Int J Antimicrob Agents , vol.27 , pp. 69-72
    • Masterton, R.G.1    Turner, P.J.2
  • 12
    • 29144493229 scopus 로고    scopus 로고
    • Prevalence and antimicrobial susceptibility data for extended-spectrum (-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004)
    • Goossens H., and Grabein B. Prevalence and antimicrobial susceptibility data for extended-spectrum (-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). Diagn Microbiol Infect Dis 53 (2005) 257-264
    • (2005) Diagn Microbiol Infect Dis , vol.53 , pp. 257-264
    • Goossens, H.1    Grabein, B.2
  • 13
    • 0036136828 scopus 로고    scopus 로고
    • Countrywide spread of CTX-M-3 extended spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland
    • Baraniak A., Fiett J., Sulikowska A., Hryniewicz W., and Gniadkowski M. Countrywide spread of CTX-M-3 extended spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother 46 (2002) 151-159
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 151-159
    • Baraniak, A.1    Fiett, J.2    Sulikowska, A.3    Hryniewicz, W.4    Gniadkowski, M.5
  • 14
    • 31944449022 scopus 로고    scopus 로고
    • Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum beta-lactamase in Austria
    • Eisner A., Fagan E.J., Feierl G., et al. Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum beta-lactamase in Austria. Antimicrob Agents Chemother 50 (2006) 785-787
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 785-787
    • Eisner, A.1    Fagan, E.J.2    Feierl, G.3
  • 15
    • 1642360049 scopus 로고    scopus 로고
    • Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001)
    • Patzer J., Toleman M.A., Lalitagauri M.D., et al. Pseudomonas aeruginosa strains harbouring an unusual blaVIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). J Antimicrob Chemother 53 (2004) 451-456
    • (2004) J Antimicrob Chemother , vol.53 , pp. 451-456
    • Patzer, J.1    Toleman, M.A.2    Lalitagauri, M.D.3
  • 16
    • 16244415883 scopus 로고    scopus 로고
    • Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centres: 6-year report of the MYSTIC surveillance study (1997-2002)
    • Turner P.J. Trends in antimicrobial susceptibilities among bacterial pathogens isolated from patients hospitalized in European medical centres: 6-year report of the MYSTIC surveillance study (1997-2002). Diagn Microbiol Infect Dis 51 (2005) 281-289
    • (2005) Diagn Microbiol Infect Dis , vol.51 , pp. 281-289
    • Turner, P.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.